Elsevier selected as new publisher of the American Journal of Geriatric Psychiatry

May 2nd, 2012
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces that it has entered into an agreement with the American Association for Geriatric Psychiatry (AAGP) to publish The American Journal of Geriatric Psychiatry (AJGP) beginning in January 2013.

"We are extremely pleased to be entering into this relationship with Elsevier," commented Chris M. deVries, Chief Executive Officer/Executive Vice President of the American Association for Geriatric Psychiatry. "The Journal serves as a primary vehicle for disseminating critical information to our national – and global – community of clinicians, educators, and researchers in the rapidly evolving fields of geriatric psychiatry and mental health. Therefore we are enthusiastic about making our content more readily accessible and discoverable through Elsevier's innovative tools, whether readers are at work, at home, or on the go."

AJGP is the authoritative source of information for the rapidly developing field of geriatric psychiatry. Each monthly issue contains peer-reviewed articles on the diagnosis and classification of psychiatric disorders in later life, epidemiological and biological correlates of mental health of older adults, and psychopharmacology and other somatic treatments. With a 3.566 Impact Factor it ranks in the top third of both the Psychiatry and Geriatrics/Gerontology categories according to Thomson Reuters' Journal Citation Reports®.

The decision to publish with Elsevier was the result of a meticulous review process. According to Editor-in-Chief Dilip V. Jeste, MD, "Key factors driving our decision were the advantages offered by Elsevier's global reach and its expertise in all phases of the publishing process. We anticipate that AJGP's position as the premier journal devoted specifically to geriatric psychiatry will be strengthened through this new association, benefiting our authors, editors, reviewers, and ultimately our readership."

Provided by Elsevier

This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.

More news stories

How does DPP-4 inhibition affect liver function?

(HealthDay)—Dipeptidyl peptidase-4 (DPP-4) inhibition may attenuate hepatic steatosis and insulin resistance induced by the Western diet (WD) through hepatic lipid remodeling and modulation of hepatic mitochondrial ...

Aircraft with a parallel hybrid engine tested in UK

More research is needed before commercial airliners will be powered entirely with electric motors but tests with hybrid designs are turning up interesting results. Researchers from the University of Cambridge ...

Amgen tops Street 4Q forecasts

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.